Does clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AIT.

Sara Huber; Roland Lang; Markus Steiner; Lorenz Aglas; Fatima Ferreira; Michael Wallner; Thomas Hawranek; Gabriele Gadermaier

doi:10.1186/s13601-018-0226-7

Does clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AIT.

Sara Huber, Roland Lang (Co-author), Markus Steiner (Co-author), Lorenz Aglas, Fatima Ferreira, Michael Wallner, Thomas Hawranek (Co-author), Gabriele Gadermaier

Department of Dermatology and Allergology
Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article (Journal) › peer-review

15 Citations (Web of Science)

Original language	English
Pages (from-to)	39
Journal	CLINICAL AND TRANSLATIONAL ALLERGY
Volume	8
DOIs	https://doi.org/10.1186/s13601-018-0226-7
Publication status	Published - 2018

Keywords

RANDOMIZED CONTROLLED-TRIAL
BET V 1
POSITION PAPER
MECHANISMS
IGG4
EPITOPES
EFFICACY
RHINOCONJUNCTIVITIS
SENSITIVITY
VACCINATION

Access to Document

10.1186/s13601-018-0226-7

Cite this

Huber, S., Lang, R., Steiner, M., Aglas, L., Ferreira, F., Wallner, M., Hawranek, T., & Gadermaier, G. (2018). Does clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AIT. CLINICAL AND TRANSLATIONAL ALLERGY, 8, 39. https://doi.org/10.1186/s13601-018-0226-7

@article{19809ef126a24f8189860b91b25290ca,

title = "Does clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AIT.",

keywords = "RANDOMIZED CONTROLLED-TRIAL, BET V 1, POSITION PAPER, MECHANISMS, IGG4, EPITOPES, EFFICACY, RHINOCONJUNCTIVITIS, SENSITIVITY, VACCINATION",

author = "Sara Huber and Roland Lang and Markus Steiner and Lorenz Aglas and Fatima Ferreira and Michael Wallner and Thomas Hawranek and Gabriele Gadermaier",

note = "Lang, Hawranek: Department of Dermatology, Paracelsus Medical University Salzburg, Salzburg, Austria; Steiner: Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Disease, Rheumatology, Oncologic Center, Laboratory for Immunological and Molecular Cancer Research, Paracelsus Medical University Salzburg, Salzburg, Austria. ",

year = "2018",

doi = "10.1186/s13601-018-0226-7",

language = "English",

volume = "8",

pages = "39",

journal = "CLINICAL AND TRANSLATIONAL ALLERGY",

issn = "2045-7022",

}

Huber, S, Lang, R , Steiner, M, Aglas, L, Ferreira, F, Wallner, M, Hawranek, T & Gadermaier, G 2018, 'Does clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AIT.', CLINICAL AND TRANSLATIONAL ALLERGY, vol. 8, pp. 39. https://doi.org/10.1186/s13601-018-0226-7

Does clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AIT. / Huber, Sara; Lang, Roland (Co-author); Steiner, Markus (Co-author) et al.
In: CLINICAL AND TRANSLATIONAL ALLERGY, Vol. 8, 2018, p. 39.

Research output: Contribution to journal › Original Article (Journal) › peer-review

TY - JOUR

T1 - Does clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AIT.

AU - Huber, Sara

AU - Lang, Roland

AU - Steiner, Markus

AU - Aglas, Lorenz

AU - Ferreira, Fatima

AU - Wallner, Michael

AU - Hawranek, Thomas

AU - Gadermaier, Gabriele

N1 - Lang, Hawranek: Department of Dermatology, Paracelsus Medical University Salzburg, Salzburg, Austria; Steiner: Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Disease, Rheumatology, Oncologic Center, Laboratory for Immunological and Molecular Cancer Research, Paracelsus Medical University Salzburg, Salzburg, Austria.

PY - 2018

Y1 - 2018

KW - RANDOMIZED CONTROLLED-TRIAL

KW - BET V 1

KW - POSITION PAPER

KW - MECHANISMS

KW - IGG4

KW - EPITOPES

KW - EFFICACY

KW - RHINOCONJUNCTIVITIS

KW - SENSITIVITY

KW - VACCINATION

U2 - 10.1186/s13601-018-0226-7

DO - 10.1186/s13601-018-0226-7

M3 - Original Article (Journal)

C2 - 30338052

SN - 2045-7022

VL - 8

SP - 39

JO - CLINICAL AND TRANSLATIONAL ALLERGY

JF - CLINICAL AND TRANSLATIONAL ALLERGY

ER -